Effects of Eleven Flavonoids from the Osteoprotective Fraction of Drynaria fortunei (KUNZE) J. SM. on Osteoblastic Proliferation Using an Osteoblast-Like Cell Line

DOI Web Site Web Site 2 Citations 59 References
  • Wang Xin-Luan
    School of Chinese Materia Medica, Shenyang Pharmaceutical University
  • Wang Nai-Li
    School of Chinese Materia Medica, Shenyang Pharmaceutical University Key Lab for New Drugs Research of Traditional Chinese Medicine, Shenzhen Research Institute of Tsinghua University
  • Zhang Yan
    State Key Laboratory of Chinese Medicine and Molecular Pharmacology
  • Gao Hao
    Key Lab for New Drugs Research of Traditional Chinese Medicine, Shenzhen Research Institute of Tsinghua University
  • Pang Wai-Yin
    Central Laboratory, Institute of Molecular Technology for Drug Discovery and Synthesis, Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University
  • Wong Man-Sau
    Central Laboratory, Institute of Molecular Technology for Drug Discovery and Synthesis, Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University
  • Zhang Ge
    Musculoskeletal Research Laboratory, Department of Orthopedics and Traumatology, Chinese University of Hong Kong
  • Qin Ling
    Musculoskeletal Research Laboratory, Department of Orthopedics and Traumatology, Chinese University of Hong Kong
  • Yao Xin-Sheng
    School of Chinese Materia Medica, Shenyang Pharmaceutical University

Bibliographic Information

Other Title
  • Effects of eleven flavonoids from osteoprotective fraction of Drynaria fortunei (KUNZE) J. SM. on osteoblastic proliferation using an osteoblast-like cell line

Search this article

Abstract

Drynaria fortunei (KUNZE) J. SM. (DFE) is one of the most frequently used traditional Chinese medicines prescribed for the treatment of osteoporosis in China. The present study was designed to investigate the osteoprotective constituents from Drynaria fortunei. The 60% ethanol extract of the rhizome of D. fortunei (DFE) was chromatographed on a D-101 macroporous resin column (φ 25×150 cm); three fractions (DFA eluted with water, DFB eluted with 30% and 50% ethanol, and DFC eluted with 95% ethanol) were obtained and their osteoprotective activity as examined both in vivo and in vitro. DFB showed significant activity on both the proliferation of UMR106 cells and promoting bone mineral density (BMD) in ovariectomized (OVX) mice. A bioactivity-guided method led to the isolation of 11 flavonoids from this fraction (DFB) with antiosteoporotic activity, including two new compounds, kaempferol 3-O-β-D-glucopyranoside-7-O-α-L-arabinofuranoside (1) and (R)-5,7,3′,5′-tetrahydroxy-flavanone 7-O-neohesperidoside (2), along with nine known ones: three flavanones (3—5), one flavone (7), one flavonol (6), two chromones (8, 10), maltol glucoside (9), and (−)-epicatechin (11). Compounds 4—11 are reported for the first time from this genus. We investigated the proliferative effects of the 11 compounds in the UMR106 osteoblastic cell line in vitro. All compounds exhibited the proliferative activity in the UMR106 cells at most of the concentrations tested. Most compounds are reported for the first time from the Drynaria genus and this was the first study of their proliferative activity in osteoblast-like cells. The main peaks in the HPLC fingerprint of the active fraction (DFB) were also identified.

Journal

Citations (2)*help

See more

References(59)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top